{"id":3,"date":"2011-11-02T20:30:00","date_gmt":"2011-11-03T00:30:00","guid":{"rendered":"https:\/\/med.sites.unc.edu\/microimm\/dittmerlab\/dittmerlab\/"},"modified":"2021-07-22T16:20:00","modified_gmt":"2021-07-22T20:20:00","slug":"dittmerlab","status":"publish","type":"page","link":"https:\/\/www.med.unc.edu\/microimm\/dittmerlab\/","title":{"rendered":"Welcome to the Dittmer Lab!"},"content":{"rendered":"

\"logo\"Current estimates suggest that 20% of all human cancers have viral origin or require viral infection as an essential cofactor. Our research seeks to understand viral tumorigenesis, specifically cancers caused by Kaposi’s sarcoma-associated herpesvirus (KSHV\/HHV-8). KSHV is a double-stranded DNA virus belonging to the Rhadinovirus family of human herpesviruses. It was discovered in 1994 and is associated with Kaposi’s sarcoma (KS) as well as B-cell cancers like primary effusion lymphoma (PEL) and multicentric Castleman’s disease (MCD). These diseases affect internal organs and are ultimately fatal; they are usually seen in the U.S. among immunosuppressed individuals like HIV-positive individuals and transplant patients.<\/p>\n

 <\/p>\n

\n
\n

Latest News<\/h2>\n\n